CardioCardio
1.
01-02 Epidemiology and Risk Factors.mp3
2.
Cardiovascular Disease in Women
3.
01-04 Ethnicity and Cardiovascular Disease.mp3
4.
01-05 Genetics in Cardiovascular Disease.mp3
5.
01-06 Question Break 1 A 62-year old Man is Seen for Dull, Substernal Chest
6.
01-07 Other Risk Factors.mp3
7.
01-08 Calculating Cardiovascular Risk.mp3
8.
01-09 Emerging Risk Factors.mp3
9.
01-10 Question Break 2 A 54-year-old Man is Seen for Crushing, Substernal C
10.
01-11 Aspirin for Primary Prevention.mp3
11.
01-12 Diagnostic Testing in Cardiology.mp3
12.
01-13 Diagnostic Testing for Coronary Artery Disease.mp3
13.
01-14 Pharmacologic Stress Testing.mp3
14.
01-15 Other Diagnostic Test for CAD.mp3
15.
01-16 Determining Which Test to Administer.mp3
16.
01-18 Interpretation of Viability Studies.mp3
17.
01-19 Visualization of the Coronary Anatomy.mp3
18.
01-20 Risks of Coronary Diagnostic Testing.mp3
19.
01-21 Session 1 Key Points.mp3
20.
02-02 Diagnostic Testing for Structural Heart Disease.mp3
21.
02-03 Diagnostic Testing for Cardiac Arrhythmias.mp3
22.
02-04 Diagnosis and Evaluation of Stable Angina Pectoris.mp3
23.
02-05 Treatment of Stable Angina Pectoris.mp3
24.
02-06 Cardioprotective Therapies.mp3
25.
02-07 Antianginal Medications.mp3
26.
02-08 Question Break 3 A 58-year-old Obese Man with Hypertension and Dyslip
27.
02-09 Coronary Revascularization.mp3
28.
02-10 PCI and CABG.mp3
29.
02-11 Goals after Revascularization.mp3
30.
02-12 Question Break 4 A 37-year-old Woman is Evaluated for Exertional Dysp
31.
02-13 Acute Coronary Syndromes.mp3
32.
02-14 ST-Segment Elevation Myocardial Infarction.mp3
33.
02-15 Reperfusion Options.mp3
34.
02-16 Characteristics of Thrombolytic Agents Used in the Treatment of STEMI
35.
02-17 Medical Therapy.mp3
36.
02-18 Choosing an Anticoagulant for Treatment of STEMI.mp3
37.
02-19 Complications of STEMI.mp3
38.
02-20 Potential Mechanical Complications of Myocardial Infarction.mp3
39.
02-21 Session 2 Key Points.mp3
40.
03-02 Non-ST-Elevation Acute Coronary Syndromes.mp3
41.
03-03 Antiplatelet Medications.mp3
42.
03-04 Anticoagulant and Antianginal Medications.mp3
43.
03-05 Invasive Versus Ischemia-Guided Treatment.mp3
44.
03-06 Acute Coronary Syndromes Not Associated with Obstructive CAD.mp3
45.
03-07 Long-Term Care After an Acute Coronary Syndrome.mp3
46.
03-08 Management of CAD in Women.mp3
47.
03-09 Question Break 5 A 68-year-old Man is Evaluated for Newly Diagnosed M
48.
03-10 Management of CAD in Patients with Diabetes.mp3
49.
03-11 Pathophysiology of Heart Failure.mp3
50.
03-12 Diagnosis and Evaluation of Heart Failure.mp3
51.
03-13 Diagnosis.mp3
52.
03-14 Diagnostic Testing.mp3
53.
03-15 Evaluation for Ischemia.mp3
54.
03-16 Question Break 6 A 19-year-old Woman is Seen with Mild Aortic Regurgi
55.
03-17 Medical Therapy for Systolic Heart Failure.mp3
56.
03-18 ACE Inhibitors, Angiotensin Receptor Blockers and Beta Blockers.mp3
57.
03-19 Initiating and Managing ACE Inhibitor and Beta-Blocker Therapy.mp3
58.
03-20 Diuretics.mp3
59.
03-21 Aldosterone Antagonists.mp3
60.
03-22 Isosorbide Dinitrate, Hydralazine and Calcium Channel Blockers.mp3
61.
04-02 Management of Heart Failure with Preserved Ejection Fraction.mp3
62.
04-03 Cardiac Resynchronization Therapy.mp3
63.
04-04 Assessment of Chronic Heart Failure and The Role of ECG.mp3
64.
04-05 Assessing Prognosis.mp3
65.
03-23 Session 3 Key Points.mp3